Literature DB >> 25567208

Anti-tumor properties of cis-resveratrol methylated analogs in metastatic mouse melanoma cells.

Valery L Morris1, Tayyaba Toseef, Fathima B Nazumudeen, Christian Rivoira, Carmela Spatafora, Corrado Tringali, Susan A Rotenberg.   

Abstract

Resveratrol (E-3,5,4'-trihydroxystilbene) is a polyphenol found in red wine that has been shown to have multiple anti-cancer properties. Although cis-(Z)- and trans-(E)-isomers of resveratrol occur in nature, the cis form is not biologically active. However, methylation at key positions of the cis form results in more potent anti-cancer properties. This study determined that synthetic cis-polymethoxystilbenes (methylated analogs of cis-resveratrol) inhibited cancer-related phenotypes of metastatic B16 F10 and non-metastatic B16 F1 mouse melanoma cells. In contrast with cis- or trans-resveratrol and trans-polymethoxystilbene which were ineffective at 10 μM, cis-polymethoxystilbenes inhibited motility and proliferation of melanoma cells with low micromolar specificity (IC50 < 10 μM). Inhibitory effects by cis-polymethoxystilbenes were significantly stronger with B16 F10 cells and were accompanied by decreased expression of β-tubulin and pleckstrin homology domain-interacting protein, a marker of metastatic B16 cells. Thus, cis-polymethoxystilbenes have potential as chemotherapeutic agents for metastatic melanoma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567208      PMCID: PMC4323743          DOI: 10.1007/s11010-014-2316-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

1.  Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration.

Authors:  C Ballestrem; B Wehrle-Haller; B Hinz; B A Imhof
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

2.  Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.

Authors:  Yann Schneider; Philippe Chabert; Jeanne Stutzmann; David Coelho; André Fougerousse; Francine Gossé; Jean-François Launay; Raymond Brouillard; Francis Raul
Journal:  Int J Cancer       Date:  2003-11-01       Impact factor: 7.396

Review 3.  A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.

Authors:  J Gusman; H Malonne; G Atassi
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

4.  Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells.

Authors:  Meng Wang; Teng Yu; Chengyao Zhu; Hui Sun; Ying Qiu; Xia Zhu; Jinchao Li
Journal:  Nutr Cancer       Date:  2014-02-28       Impact factor: 2.900

5.  Potential mechanism by which resveratrol, a red wine constituent, protects neurons.

Authors:  Hean Zhuang; Yun-Sook Kim; Raymond C Koehler; Sylvain Doré
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

Review 6.  Human relevance of NRAS/BRAF mouse melanoma models.

Authors:  Alejandro Conde-Perez; Lionel Larue
Journal:  Eur J Cell Biol       Date:  2013-11-04       Impact factor: 4.492

7.  Inhibition of protein kinase C by resveratrol.

Authors:  Simon J Slater; Jodie L Seiz; Anthony C Cook; Brigid A Stagliano; Christopher J Buzas
Journal:  Biochim Biophys Acta       Date:  2003-01-20

8.  Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis.

Authors:  Kashif Adil Ahmad; Marie-Veronique Clement; Shazib Pervaiz
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

9.  Resveratrol couples apoptosis with autophagy in UVB-irradiated HaCaT cells.

Authors:  Nicoletta Vitale; Annamaria Kisslinger; Simona Paladino; Claudio Procaccini; Giuseppe Matarese; Giovanna Maria Pierantoni; Francesco Paolo Mancini; Donatella Tramontano
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

10.  3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.

Authors:  Michał Cichocki; Wanda Baer-Dubowska; Marcin Wierzchowski; Marek Murias; Jadwiga Jodynis-Liebert
Journal:  Mol Cell Biochem       Date:  2014-02-13       Impact factor: 3.396

View more
  6 in total

1.  3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.

Authors:  Fahad S Aldawsari; Carlos A Velázquez-Martínez
Journal:  Invest New Drugs       Date:  2015-02-28       Impact factor: 3.850

Review 2.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

3.  3,3',4,5'-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress.

Authors:  Yi Tan; Lingchao Miao; Jianbo Xiao; Wai San Cheang
Journal:  Curr Issues Mol Biol       Date:  2022-05-12       Impact factor: 2.976

Review 4.  Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?

Authors:  Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

5.  TCTP as a therapeutic target in melanoma treatment.

Authors:  M Boia-Ferreira; A B Basílio; A E Hamasaki; F H Matsubara; M H Appel; C R V Da Costa; R Amson; A Telerman; O M Chaim; S S Veiga; A Senff-Ribeiro
Journal:  Br J Cancer       Date:  2017-07-27       Impact factor: 7.640

6.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.